Hematopoietic stem cell fate decisions are regulated by Wnt antagonists: Comparisons and current controversies

Experimental Hematology

Volumn 41, Issue 1, 2013, Pages 3-16

  Cain, Corey J ^a   Manilay, Jennifer O ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CALCIUM ION; DICKKOPF 1 PROTEIN; DICKKOPF 2 PROTEIN; DICKKOPF 3 PROTEIN; DICKKOPF 4 PROTEIN; DISHEVELLED PROTEIN; FRIZZLED PROTEIN; GLYCOPROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 4; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; LYMPHOID ENHANCER FACTOR; SCLEROSTIN; SECRETED FRIZZLED RELATED PROTEIN 1; SECRETED FRIZZLED RELATED PROTEIN 2; STRESS ACTIVATED PROTEIN KINASE; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG; WNT INHIBITORY FACTOR 1; WNT PROTEIN; WNT5A PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; B CELL LYMPHOMA; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL COUNT; CELL DIFFERENTIATION; CELL EXPANSION; CELL FATE; CELL LINEAGE; CELL MATURATION; CELL POLARITY; CELL PROLIFERATION; CELL RENEWAL; CELL SURVIVAL; COLONY FORMING UNIT; DOWN REGULATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; MULTIPLE MYELOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REVIEW; UPREGULATION; WNT SIGNALING PATHWAY;

ANIMALS; B-LYMPHOCYTES; BONE MORPHOGENETIC PROTEINS; CALCIUM; CELL DIFFERENTIATION; GENETIC MARKERS; GLYCOPROTEINS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LYMPHOID ENHANCER-BINDING FACTOR 1; MEMBRANE PROTEINS; RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTORS; WNT PROTEINS; WNT SIGNALING PATHWAY;

MUS;

EID: 84870932517     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2012.09.006     Document Type: Review

References (112)

1. Pacifici R. The immune system and bone. Arch Biochem Biophys 2010, 503:41-53.
2. Li L., Xie T. Stem cell niche: structure and function. Annu Rev Cell Dev Biol 2005, 21:605-631.
3. Wilusz M., Majka M. Role of the Wnt/beta-catenin network in regulating hematopoiesis. Arch Immunol Ther Exp (Warsz) 2008, 56:257-266.
4. Cadigan K.M., Nusse R. Wnt signaling: a common theme in animal development. Genes Dev 1997, 11:3286-3305.
5. Kilander M.B., Dijksterhuis J.P., Ganji R.S., Bryja V., Schulte G. WNT-5A stimulates the GDP/GTP exchange at pertussis toxin-sensitive heterotrimeric G proteins. Cell Signal 2011, 23:550-554.
6. Koval A., Katanaev V.L. Wnt3a stimulation elicits G-protein-coupled receptor properties of mammalian Frizzled proteins. Biochem J 2011, 433:435-440.
7. Schulte G., Bryja V. The Frizzled family of unconventional G-protein-coupled receptors. Trends Pharmacol Sci 2007, 28:518-525.
8. Nemeth M.J., Bodine D.M. Regulation of hematopoiesis and the hematopoietic stem cell niche by Wnt signaling pathways. Cell Res 2007, 17:746-758.
9. Malhotra S., Kincade P.W. Wnt-related molecules and signaling pathway equilibrium in hematopoiesis. Cell Stem Cell 2009, 4:27-36.
10. Li V.S., Ng S.S., Boersema P.J., et al. Wnt signaling through inhibition of beta-catenin degradation in an intact Axin1 complex. Cell 2012, 149:1245-1256.
11. Choi H.Y., Dieckmann M., Herz J., Niemeier A. Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo. PloS One 2009, 4:e7930.
12. Cain C.J., Rueda R., McLelland B., Collette N.M., Loots G.G., Manilay J.O. Absence of sclerostin adversely affects B-cell survival. J Bone Miner Res 2012, 27:1451-1461.
13. Tu X., Joeng K.S., Nakayama K.I., et al. Noncanonical Wnt signaling through G protein-linked PKCdelta activation promotes bone formation. Dev Cell 2007, 12:113-127.
14. Staal F.J., Luis T.C., Tiemessen M.M. WNT signalling in the immune system: WNT is spreading its wings. Nat Rev 2008, 8:581-593.
15. Grumolato L., Liu G., Mong P., et al. Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes Dev 2010, 24:2517-2530.
16. Kuhl M., Sheldahl L.C., Malbon C.C., Moon R.T. Ca(2+)/calmodulin-dependent protein kinase II is stimulated by Wnt and Frizzled homologs and promotes ventral cell fates in Xenopus. J Biol Chem 2000, 275:12701-12711.
17. Sheldahl L.C., Park M., Malbon C.C., Moon R.T. Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in a G-protein-dependent manner. Curr Biol 1999, 9:695-698.
18. Slusarski D.C., Corces V.G., Moon R.T. Interaction of Wnt and a Frizzled homologue triggers G-protein-linked phosphatidylinositol signalling. Nature 1997, 390:410-413.
19. De A. Wnt/Ca2+ signaling pathway: a brief overview. Acta Biochim Biophys Sin (Shanghai) 2011, 43:745-756.
20. Seita J., Weissman I.L. Hematopoietic stem cell: self-renewal versus differentiation. Wiley Interdiscip Rev Syst Biol Med 2010, 2:640-653.
21. Mercier F.E., Ragu C., Scadden D.T. The bone marrow at the crossroads of blood and immunity. Nat Rev 2011, 12:49-60.
22. Horowitz M.C., Fretz J.A. Sclerostin: a new mediator of crosstalk between the skeletal and immune systems. J Bone Miner Res 2012, 27:1448-1450.
23. Oh I.H., Humphries R.K. Concise review: multidimensional regulation of the hematopoietic stem cell state. Stem Cells 2012, 30:82-88.
24. Nemeth M.J., Mak K.K., Yang Y., Bodine D.M. Beta-catenin expression in the bone marrow microenvironment is required for long-term maintenance of primitive hematopoietic cells. Stem Cells 2009, 27:1109-1119.
25. Reya T., Duncan A.W., Ailles L., et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 2003, 423:409-414.
26. Jeannet G., Scheller M., Scarpellino L., et al. Long-term, multilineage hematopoiesis occurs in the combined absence of beta-catenin and gamma-catenin. Blood 2008, 111:142-149.
27. Koch U., Wilson A., Cobas M., Kemler R., Macdonald H.R., Radtke F. Simultaneous loss of beta- and gamma-catenin does not perturb hematopoiesis or lymphopoiesis. Blood 2008, 111:160-164.
28. Zhao C., Blum J., Chen A., et al. Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 2007, 12:528-541.
29. Nemeth M.J., Topol L., Anderson S.M., Yang Y., Bodine D.M. Wnt5a inhibits canonical Wnt signaling in hematopoietic stem cells and enhances repopulation. Proc Natl Acad Sci U S A 2007, 104:15436-15441.
30. Austin T.W., Solar G.P., Ziegler F.C., Liem L., Matthews W. A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells. Blood 1997, 89:3624-3635.
31. Hausler K.D., Horwood N.J., Chuman Y., et al. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation. J Bone Miner Res 2004, 19:1873-1881.
32. Buckley S.M., Ulloa-Montoya F., Abts D., et al. Maintenance of HSC by Wnt5a secreting AGM-derived stromal cell line. Exp Hematol 2011, 39:114-123. e111-e115.
33. Murdoch B., Chadwick K., Martin M., et al. Wnt-5A augments repopulating capacity and primitive hematopoietic development of human blood stem cells in vivo. Proc Natl Acad Sci U S A 2003, 100:3422-3427.
34. Vijayaragavan K., Szabo E., Bosse M., Ramos-Mejia V., Moon R.T., Bhatia M. Noncanonical Wnt signaling orchestrates early developmental events toward hematopoietic cell fate from human embryonic stem cells. Cell Stem Cell 2009, 4:248-262.
35. Heinonen K.M., Vanegas J.R., Lew D., Krosl J., Perreault C. Wnt4 enhances murine hematopoietic progenitor cell expansion through a planar cell polarity-like pathway. PloS One 2011, 6:e19279.
36. Ho H.Y., Susman M.W., Bikoff J.B., et al. Wnt5a-Ror-dishevelled signaling constitutes a core developmental pathway that controls tissue morphogenesis. Proc Natl Acad Sci U S A 2012, 109:4044-4051.
37. Louis I., Heinonen K.M., Chagraoui J., Vainio S., Sauvageau G., Perreault C. The signaling protein Wnt4 enhances thymopoiesis and expands multipotent hematopoietic progenitors through beta-catenin-independent signaling. Immunity 2008, 29:57-67.
38. Kim D.J., Park C.S., Yoon J.K., Song W.K. Differential expression of the Wnt and Frizzled genes in Flk1+ cells derived from mouse ES cells. Cell Biochem Function 2008, 26:24-32.
39. Clements W.K., Kim A.D., Ong K.G., Moore J.C., Lawson N.D., Traver D. A somitic Wnt16/Notch pathway specifies haematopoietic stem cells. Nature 2011, 474:220-224.
40. Corrigan P.M., Dobbin E., Freeburn R.W., Wheadon H. Patterns of Wnt/Fzd/LRP gene expression during embryonic hematopoiesis. Stem Cells Dev 2009, 18:759-772.
41. Jin Z.X., Kishi H., Wei X.C., Matsuda T., Saito S., Muraguchi A. Lymphoid enhancer-binding factor-1 binds and activates the recombination-activating gene-2 promoter together with c-Myb and Pax-5 in immature B cells. J Immunol 2002, 169:3783-3792.
42. Christian S.L., Sims P.V., Gold M.R. The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3. J Immunol 2002, 169:758-769.
43. Reya T., O'Riordan M., Okamura R., et al. Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. Immunity 2000, 13:15-24.
44. Cobas M., Wilson A., Ernst B., et al. Beta-catenin is dispensable for hematopoiesis and lymphopoiesis. J Exp Med 2004, 199:221-229.
45. Scheller M., Huelsken J., Rosenbauer F., et al. Hematopoietic stem cell and multilineage defects generated by constitutive beta-catenin activation. Nat Immunol 2006, 7:1037-1047.
46. Yu Q., Quinn W.J., Salay T., Crowley J.E., Cancro M.P., Sen J.M. Role of beta-catenin in B cell development and function. J Immunol 2008, 181:3777-3783.
47. Ranheim E.A., Kwan H.C., Reya T., Wang Y.K., Weissman I.L., Francke U. Frizzled 9 knock-out mice have abnormal B-cell development. Blood 2005, 105:2487-2494.
48. Liang H., Chen Q., Coles A.H., et al. Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell 2003, 4:349-360.
49. Sercan Z., Pehlivan M., Sercan H.O. Expression profile of WNT, FZD and sFRP genes in human hematopoietic cells. Leuk Res 2010, 34:946-949.
50. Luis T.C., Naber B.A., Roozen P.P., et al. Canonical wnt signaling regulates hematopoiesis in a dosage-dependent fashion. Cell Stem Cell 2011, 9:345-356.
51. Malhotra S., Baba Y., Garrett K.P., Staal F.J., Gerstein R., Kincade P.W. Contrasting responses of lymphoid progenitors to canonical and noncanonical Wnt signals. J Immunol 2008, 181:3955-3964.
52. Sugimura R., He X.C., Venkatraman A., et al. Noncanonical wnt signaling maintains hematopoietic stem cells in the niche. Cell 2012, 150:351-365.
53. Chien A.J., Conrad W.H., Moon R.T. A Wnt survival guide: from flies to human disease. J Invest Dermatol 2009, 129:1614-1627.
54. Bovolenta P., Esteve P., Ruiz J.M., Cisneros E., Lopez-Rios J. Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease. J Cell Sci 2008, 121:737-746.
55. Lopez-Rios J., Esteve P., Ruiz J.M., Bovolenta P. The Netrin-related domain of Sfrp1 interacts with Wnt ligands and antagonizes their activity in the anterior neural plate. Neural Dev 2008, 3:19.
56. Nakajima H., Ito M., Morikawa Y., et al. Wnt modulators, SFRP-1, and SFRP-2 are expressed in osteoblasts and differentially regulate hematopoietic stem cells. Biochem Biophys Res Commun 2009, 390:65-70.
57. Renstrom J., Istvanffy R., Gauthier K., et al. Secreted frizzled-related protein 1 extrinsically regulates cycling activity and maintenance of hematopoietic stem cells. Cell Stem Cell 2009, 5:157-167.
58. Monroe D.G., McGee-Lawrence M.E., Oursler M.J., Westendorf J.J. Update on Wnt signaling in bone cell biology and bone disease. Gene 2012, 492:1-18.
59. Bodine P.V., Komm B.S. Wnt signaling and osteoblastogenesis. Rev Endocr Metab Disord 2006, 7:33-39.
60. Ding L., Saunders T.L., Enikolopov G., Morrison S.J. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 2012, 481:457-462.
61. Calvi L.M., Adams G.B., Weibrecht K.W., et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003, 425:841-846.
62. Zhang J., Niu C., Ye L., et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003, 425:836-841.
63. Sugiyama T., Kohara H., Noda M., Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006, 25:977-988.
64. Kiel M.J., Morrison S.J. Maintaining hematopoietic stem cells in the vascular niche. Immunity 2006, 25:862-864.
65. Mendez-Ferrer S., Michurina T.V., Ferraro F., et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466:829-834.
66. Porter R.L., Calvi L.M. Communications between bone cells and hematopoietic stem cells. Arch Biochem Biophys 2008, 473:193-200.
67. Bodine P.V., Zhao W., Kharode Y.P., et al. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol Endocrinol 2004, 18:1222-1237.
68. Arai F., Suda T. Maintenance of quiescent hematopoietic stem cells in the osteoblastic niche. Ann N Y Acad Sci 2007, 1106:41-53.
69. Satoh W., Gotoh T., Tsunematsu Y., Aizawa S., Shimono A. Sfrp1 and Sfrp2 regulate anteroposterior axis elongation and somite segmentation during mouse embryogenesis. Development 2006, 133:989-999.
70. Satoh W., Matsuyama M., Takemura H., Aizawa S., Shimono A. Sfrp1, Sfrp2, and Sfrp5 regulate the Wnt/beta-catenin and the planar cell polarity pathways during early trunk formation in mouse. Genesis 2008, 46:92-103.
71. Cheng Y.H., Chitteti B.R., Streicher D.A., et al. Impact of osteoblast maturational status on their ability to enhance the hematopoietic function of stem and progenitor cells. J Bone Miner Res 2011, 26:1111-1121.
72. Roux S. New treatment targets in osteoporosis. Joint Bone Spine 2010, 77:222-228.
73. Surmann-Schmitt C., Widmann N., Dietz U., et al. Wif-1 is expressed at cartilage-mesenchyme interfaces and impedes Wnt3a-mediated inhibition of chondrogenesis. J Cell Sci 2009, 122:3627-3637.
74. Hsieh J.C., Kodjabachian L., Rebbert M.L., et al. A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature 1999, 398:431-436.
75. Kawano Y., Kypta R. Secreted antagonists of the Wnt signalling pathway. J Cell Sci 2003, 116:2627-2634.
76. Malinauskas T., Aricescu A.R., Lu W., Siebold C., Jones E.Y. Modular mechanism of Wnt signaling inhibition by Wnt inhibitory factor 1. Nat Struct Mol Biol 2011, 18:886-893.
77. Fradkin L.G., Dura J.M., Noordermeer J.N. Ryks: new partners for Wnts in the developing and regenerating nervous system. Trends Neurosci 2010, 33:84-92.
78. Patthy L. The WIF module. Trends Biochem Sci 2000, 25:12-13.
79. Vaes B.L., Dechering K.J., van Someren E.P., et al. Microarray analysis reveals expression regulation of Wnt antagonists in differentiating osteoblasts. Bone 2005, 36:803-811.
80. Schaniel C., Sirabella D., Qiu J., Niu X., Lemischka I.R., Moore K.A. Wnt-inhibitory factor 1 dysregulation of the bone marrow niche exhausts hematopoietic stem cells. Blood 2011, 118:2420-2429.
81. Kiel M.J., Morrison S.J. Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev 2008, 8:290-301.
82. Bhat B.M., Allen K.M., Liu W., et al. Structure-based mutation analysis shows the importance of LRP5 beta-propeller 1 in modulating Dkk1-mediated inhibition of Wnt signaling. Gene 2007, 391:103-112.
83. Mao B., Wu W., Li Y., et al. LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 2001, 411:321-325.
84. Semenov M.V., Tamai K., Brott B.K., Kuhl M., Sokol S., He X. Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr Biol 2001, 11:951-961.
85. Mao B., Wu W., Davidson G., et al. Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature 2002, 417:664-667.
86. Niehrs C. Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 2006, 25:7469-7481.
87. Ellwanger K., Saito H., Clement-Lacroix P., et al. Targeted disruption of the Wnt regulator Kremen induces limb defects and high bone density. Mol Cell Biol 2008, 28:4875-4882.
88. Morvan F., Boulukos K., Clement-Lacroix P., et al. Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res 2006, 21:934-945.
89. Fleming H.E., Janzen V., Lo Celso C., et al. Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo. Cell Stem Cell 2008, 2:274-283.
90. Aicher A., Kollet O., Heeschen C., et al. The Wnt antagonist Dickkopf-1 mobilizes vasculogenic progenitor cells via activation of the bone marrow endosteal stem cell niche. Circ Res 2008, 103:796-803.
91. Yao G.Q., Wu J.J., Troiano N., Insogna K. Targeted overexpression of Dkk1 in osteoblasts reduces bone mass but does not impair the anabolic response to intermittent PTH treatment in mice. J Bone Mineral Metab 2011, 29:141-148.
92. van Bezooijen R.L., ten Dijke P., Papapoulos S.E., Lowik C.W. SOST/sclerostin, an osteocyte-derived negative regulator of bone formation. Cytokine Growth Factor Rev 2005, 16:319-327.
93. Semenov M., Tamai K., He X. SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J Biol Chem 2005, 280:26770-26775.
94. Kamiya N., Ye L., Kobayashi T., et al. BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway. Development 2008, 135:3801-3811.
95. Bilezikian J.P., Raisz L.G., Martin T.J. Principles of Bone Biology 2008, Academic Press/Elsevier, San Diego, CA. 3rd ed.
96. Kramer I., Loots G.G., Studer A., Keller H., Kneissel M. Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice. J Bone Miner Res 2010, 25:178-189.
97. Loots G.G., Kneissel M., Keller H., et al. Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease. Genome Res 2005, 15:928-935.
98. Li X., Ominsky M.S., Niu Q.T., et al. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res 2008, 23:860-869.
99. Krause C., Korchynskyi O., de Rooij K., et al. Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways. J Biol Chem 2010, 285:41614-41626.
100. Tagaya H., Kunisada T., Yamazaki H., et al. Intramedullary and extramedullary B lymphopoiesis in osteopetrotic mice. Blood 2000, 95:3363-3370.
101. Chim C.S., Chan W.W., Pang A., Kwong Y.L. Preferential methylation of Wnt inhibitory factor-1 in acute promyelocytic leukemia: an independent poor prognostic factor. Leukemia 2006, 20:907-909.
102. Hou H.A., Kuo Y.Y., Liu C.Y., et al. Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia. Br J Cancer 2011, 105:1927-1933.
103. Jost E., Schmid J., Wilop S., et al. Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia. Br J Haematol 2008, 142:745-753.
104. Lane S.W., Wang Y.J., Lo Celso C., et al. Differential niche and Wnt requirements during acute myeloid leukemia progression. Blood 2011, 118:2849-2856.
105. Brunetti G., Oranger A., Mori G., et al. Sclerostin is overexpressed by plasma cells from multiple myeloma patients. Ann N Y Acad Sci 2011, 1237:19-23.
106. Giuliani N., Morandi F., Tagliaferri S., et al. Production of Wnt inhibitors by myeloma cells: potential effects on canonical Wnt pathway in the bone microenvironment. Cancer Res 2007, 67:7665-7674.
107. Tian E., Zhan F., Walker R., et al. The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 2003, 349:2483-2494.
108. Yokota T., Oritani K., Garrett K.P., et al. Soluble frizzled-related protein 1 is estrogen inducible in bone marrow stromal cells and suppresses the earliest events in lymphopoiesis. J Immunol 2008, 181:6061-6072.
109. Maretto S., Cordenonsi M., Dupont S., et al. Mapping Wnt/beta-catenin signaling during mouse development and in colorectal tumors. Proc Natl Acad Sci U S A 2003, 100:3299-3304.
110. DasGupta R., Fuchs E. Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation. Development 1999, 126:4557-4568.
111. Ferrer-Vaquer A., Piliszek A., Tian G., Aho R.J., Dufort D., Hadjantonakis A.K. A sensitive and bright single-cell resolution live imaging reporter of Wnt/ss-catenin signaling in the mouse. BMC Dev Biol 2010, 10:121.
112. Oshima T., Abe M., Asano J., et al. Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2. Blood 2005, 106:3160-3165.